These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15966284)

  • 1. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid rescreening of cervical smears for internal quality control.
    Diehl AR; Prolla JC
    Acta Cytol; 1998; 42(4):949-53. PubMed ID: 9684583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
    Rowe LR; Marshall CJ; Bentz JS
    Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen?
    Farrell DJ; Bilkhu S; Gibson LM; Cummings L; Wadehra V
    Acta Cytol; 1997; 41(2):251-60. PubMed ID: 9100751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid rescreening of cervical smears as a quality control method in a high-risk population.
    Michelow P; McKee G; Hlongwane F
    Cytopathology; 2006 Jun; 17(3):110-5. PubMed ID: 16719852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False negative rate of cervical cytologic smear screening as determined by rapid rescreening.
    Renshaw AA; Bellerose B; DiNisco SA; Minter LJ; Lee KR
    Acta Cytol; 1999; 43(3):344-50. PubMed ID: 10349360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid rescreening of cervical smears: an improved method of quality control.
    Dudding N
    Cytopathology; 1995 Apr; 6(2):95-9. PubMed ID: 7795170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
    Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
    Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
    O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
    JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 100% rapid (partial) rescreening for quality assurance.
    Lemay C; Meisels A
    Acta Cytol; 1999; 43(1):86-8. PubMed ID: 9987456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescreening in gynecologic cytology. Rescreening of 8096 previous cases for current low-grade and indeterminate-grade squamous intraepithelial lesion diagnoses--a College of American Pathologists Q-Probes study of 323 laboratories.
    Jones BA
    Arch Pathol Lab Med; 1996 Jun; 120(6):519-22. PubMed ID: 8651851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory.
    Mattosinho de Castro Ferraz Mda G; Dall' Agnol M; di Loreto C; Pirani WM; Utagawa ML; Pereira SM; Sakai YI; Feres CL; Shih LW; Yamamoto LS; Rodrigues RO; Shirata NK; Longatta Filho A
    Acta Cytol; 2005; 49(6):639-43. PubMed ID: 16450904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.